Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
959 35 |
Ultima descărcare din IBN: 2024-01-16 14:58 |
Căutarea după subiecte similare conform CZU |
616.36-003.826-06-085 (1) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1698) |
SM ISO690:2012 , , DUMBRAVA, Vlada-Tatiana, HAREA, Gheorghe, , , , , CEBANU, Ecaterina, , , CUMPĂTĂ, Veronica. Sindromul metabolic și steatoza hepatică. In: Sănătate Publică, Economie şi Management în Medicină , 2016, nr. 4(68), pp. 60-65. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | |||||
Numărul 4(68) / 2016 / ISSN 1729-8687 /ISSNe 2587-3873 | |||||
|
|||||
CZU: 616.36-003.826-06-085 | |||||
Pag. 60-65 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Metabolic syndrome (MS) is a complex of risk factors that occur as a result of the combination of insulin resistance, depositing excess of body fat (visceral abdominal, blood vessels, internal organs including liver and pancreas), with a major impact on cardio-vascular system, frequently accompanied by liver involvement. The aim of this study was to detect the frequency of liver alteration associated with MS, in patients that addressed the consultation of a gastroenterologist. Of 263 patients who were seen by a gastroenterologist, in 85 (32,7%) were diagnosed MS. The average age was 50,95 years, the ratio males: females – 1: 1.02. In 80 (94,12%) patients of the studied group with MS was established hepatic involvement: non-alcoholic fatty liver disease, (NAFLD) – 27 (33,75%) cases, chronic viral infection (B, C, D) in 10 (12,5%) cases, the association of chronic viral infection and liver steatosis – 43 (53,75%) cases. In 5 (5,88%) cases were diagnosed other pathologies of gastrointestinal tract: chronic pancreatitis, chronic cholecystitis, gastroesophageal reflux disease. MS is meeting frequently in patients with hepatic pathology of different etiology. Non-alcoholic liver steatosis is a risk factor commonly associated with MS, therefore the clinician has to be ready in diagnosing this pathology on outpatients level in order to stop the chronic hepatic disease unfavorable evolution and progression. |
|||||
Cuvinte-cheie metabolic syndrome, hepatic steatosis |
|||||
|